Maverick Therapeutics IPO

Maverick Therapeutics is a biotech company developing a T cell therapeutic platform designed to eliminate solid tumors. With the platform, T cell activation and resulting cell killing only take place where it is needed, therefore delivering the long sought trifecta in cancer care; high specificity, high potency and reduced toxicity.